(Q44721490)

5 December 2017

Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy (English)

1 reference

5 December 2017

1 reference

ChEBI release 2020-05-28

1 reference

Takahisa Hanada

1

1 reference

5 December 2017

Yutaka Hashizume

2

1 reference

5 December 2017

Naoki Tokuhara

3

1 reference

5 December 2017

Osamu Takenaka

4

1 reference

5 December 2017

Naohiro Kohmura

5

1 reference

5 December 2017

Aichi Ogasawara

6

1 reference

5 December 2017

Shinji Hatakeyama

7

1 reference

5 December 2017

Makoto Ohgoh

8

1 reference

5 December 2017

Masataka Ueno

9

1 reference

5 December 2017

Yukio Nishizawa

10

1 reference

5 December 2017

2 June 2011

1 reference

5 December 2017

1 reference

5 December 2017

52

1 reference

5 December 2017

7

1 reference

5 December 2017

1331-1340

1 reference

Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures

5 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Molecular mechanism of AMPA receptor noncompetitive antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on kindling acquisition and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Comparison of the effect of glutamate receptor modulators in the 6 Hz and maximal electroshock seizure models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Key factors in the discovery and development of new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

A crossover, add-on trial of talampanel in patients with refractory partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Pathophysiological mechanisms of genetic absence epilepsy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Phenytoin's effect on the spread of seizure activity in the amygdala kindling model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Inhibition by chloral hydrate and trichloroethanol of AMPA-induced Ca(2+) influx in rat cultured cortical neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Effect of YM872, a selective and highly water-soluble AMPA receptor antagonist, in the rat kindling and rekindling model of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Talampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Molecular targets for antiepileptic drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Development of new antiepileptic drugs: challenges, incentives, and recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Diverse mechanisms of antiepileptic drugs in the development pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

The neurobiology of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Mechanisms of action of antiepileptic drugs: the search for synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

Activity profile of pregabalin in rodent models of epilepsy and ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

AMPA receptor antagonists for the treatment of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03109.X

10.1111/J.1528-1167.2011.03109.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference